Disclosure Quest - Search SEC Filings

Name	Type of Offering	Accepted Date
Emerald Health Bioceuticals Inc. See All Filings	1-A/A	2020-03-20 19:34:33 UTC
Amount To Be Raised $50,000,000 Associated Brokers / Dealers N/A CIK Number 0001713164 Filed Document 0001594062-20-000021 Accepted Date 2020-03-20 19:34:33 UTC Type of Offering 1-A/A Industry PHARMACEUTICAL PREPARATIONS Offering Tier Tier2 Principal Place of Business CALIFORNIA Revenue or Assets $654,493 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Emerald Health Bioceuticals Inc. See All Filings	D	2020-03-19 17:01:42 UTC
Amount To Be Raised $5,000,000 Associated Brokers / Dealers N/A CIK Number 0001713164 Filed Document 0001567619-20-006776 Exclusions or Exemptions 506b Accepted Date 2020-03-19 17:01:42 UTC Type of Offering D Industry Retailing Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Emerald Health Bioceuticals Inc. See All Filings	1-A	2020-02-14 17:46:09 UTC
Amount To Be Raised $50,000,000 Associated Brokers / Dealers N/A CIK Number 0001713164 Filed Document 0001594062-20-000010 Accepted Date 2020-02-14 17:46:09 UTC Type of Offering 1-A Industry PHARMACEUTICAL PREPARATIONS Offering Tier Tier2 Principal Place of Business CALIFORNIA Revenue or Assets $654,493 State of Jurisdiction DELAWARE Type of Security Equity (common or preferred stock)
Emerald Health Bioceuticals Inc. See All Filings	D/A	2017-08-17 13:15:23 UTC
Amount To Be Raised $127,006 Associated Brokers / Dealers N/A CIK Number 0001713164 Filed Document 0001713164-17-000002 Exclusions or Exemptions 506b Accepted Date 2017-08-17 13:15:23 UTC Type of Offering D/A Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity
Emerald Health Bioceuticals Inc. See All Filings	D	2017-07-27 11:17:27 UTC
Amount To Be Raised $23,740 Associated Brokers / Dealers N/A CIK Number 0001713164 Filed Document 0001713164-17-000001 Exclusions or Exemptions 506b Accepted Date 2017-07-27 11:17:27 UTC Type of Offering D Industry Biotechnology Principal Place of Business CALIFORNIA Revenue or Assets Decline to Disclose Type of Security Equity